Drug Profile
PRO 02
Alternative Names: PRO-02Latest Information Update: 05 Oct 2023
Price :
$50
*
At a glance
- Originator Prothix
- Class Monoclonal antibodies
- Mechanism of Action Complement system protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Liver-kidney transplant rejection; Reperfusion injury
Most Recent Events
- 05 Oct 2023 Discontinued - Preclinical for Liver-kidney transplant rejection in Netherlands (unspecified route)
- 05 Oct 2023 Discontinued - Preclinical for Reperfusion injury (Prevention) in Netherlands (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Liver-kidney-transplant-rejection in Netherlands